The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selby, M.
Right arrow Articles by Walker, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selby, M.
Right arrow Articles by Walker, C. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 1999, 162: 669-676.
Copyright © 1999 by The American Association of Immunologists

Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules1

Mark Selby*, Ann Erickson*, Christine Dong*, Stewart Cooper{dagger}, Peter Parham{dagger}, Michael Houghton* and Christopher M. Walker2,*

* Chiron Corp., Emeryville, CA 94608; and {dagger} Department of Structural Biology, Stanford University, Stanford, CA 94305

We investigated whether hepatitis C virus envelope glycoprotein E1 is transported from the endoplasmic reticulum (ER) to the cytoplasm of infected cells for class I MHC processing. Target cells expressing E1 were killed by CTL lines from a hepatitis C virus-infected chimpanzee, and synthetic peptides were used to define an epitope (amino acids 233-GNASRCWVA-241) presented by the Patr-B*1601 class I MHC molecule. An unusually high concentration (>100 nM) of this nonameric peptide was required for target cell lysis, but this could be reduced at least 1000-fold by replacing the asparagine at amino acid position 234 (Asn234) with aspartic acid (Asp), the anticipated anchor residue for NH2-terminal peptide binding to Patr-B*1601. Conspicuously, position 234 is part of an N-glycosylation motif (Asn-Xaa-Ser/Thr), suggesting that the Asn234 to Asp substitution might occur naturally within the cell due to deglycosylation/deamidation of this amino acid by the cytosolic enzyme peptide N-glycanase. In support of this model, we demonstrate that presentation of the epitope depended on 1) cotranslational synthesis of E1 in the ER, 2) glycosylation of the E1 molecule, and 3) a functional TAP transporter to shuttle peptide from the cytosolic to ER compartment. These results indicate for the first time that during infection of the host, viral envelope glycoproteins originating in the ER are processed in the cytoplasm for class I MHC presentation. That a posttranslational change in amino acid sequence from Asn to Asp alters the repertoire of peptides presented to CD8+ CTL has implications for the design of antiviral vaccines.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Tiwari, N. Garbi, T. Reinheckel, G. Moldenhauer, G. J. Hammerling, and F. Momburg
A Transporter Associated with Antigen-Processing Independent Vacuolar Pathway for the MHC Class I-Mediated Presentation of Endogenous Transmembrane Proteins
J. Immunol., June 15, 2007; 178(12): 7932 - 7942.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Altrich-VanLith, M. Ostankovitch, J. M. Polefrone, C. A. Mosse, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard
Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases
J. Immunol., October 15, 2006; 177(8): 5440 - 5450.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. F. Wieland and F. V. Chisari
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
J. Virol., August 1, 2005; 79(15): 9369 - 9380.
[Full Text] [PDF]


Home page
J. Virol.Home page
Y. V. Svitkin, A. Pause, M. Lopez-Lastra, S. Perreault, and N. Sonenberg
Complete Translation of the Hepatitis C Virus Genome In Vitro: Membranes Play a Critical Role in the Maturation of All Virus Proteins except for NS3
J. Virol., June 1, 2005; 79(11): 6868 - 6881.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Zhang, B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin
Glycobiology, December 1, 2004; 14(12): 1229 - 1246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sidney, S. Southwood, V. Pasquetto, and A. Sette
Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype
J. Immunol., December 1, 2003; 171(11): 5964 - 5974.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Meyer-Olson, K. W. Brady, J. T. Blackard, T. M. Allen, S. Islam, N. H. Shoukry, K. Hartman, C. M. Walker, and S. A. Kalams
Analysis of the TCR {beta} Variable Gene Repertoire in Chimpanzees: Identification of Functional Homologs to Human Pseudogenes
J. Immunol., April 15, 2003; 170(8): 4161 - 4169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. N. Golovina, E. J. Wherry, T. N. J. Bullock, and L. C. Eisenlohr
Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum
J. Immunol., March 15, 2002; 168(6): 2667 - 2675.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
G. Lautscham, S. Mayrhofer, G. Taylor, T. Haigh, A. Leese, A. Rickinson, and N. Blake
Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for CD8+ T Cell Recognition Reveals a Proteasome-dependent, Transporter Associated with Antigen Processing-independent Pathway
J. Exp. Med., October 8, 2001; 194(8): 1053 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Tangri, G. Y. Ishioka, X. Huang, J. Sidney, S. Southwood, J. Fikes, and A. Sette
Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes that Are More Potent and Immunogenic than Wild-Type Peptide
J. Exp. Med., September 17, 2001; 194(6): 833 - 846.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bai, C. J. Aldrich, and J. Forman
Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1
J. Immunol., December 15, 2000; 165(12): 7025 - 7034.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lopez, B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val
Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation
J. Immunol., May 15, 2000; 164(10): 5070 - 5077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Hudrisier, J. Riond, H. Mazarguil, M. B. A. Oldstone, and J. E. Gairin
Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes
J. Biol. Chem., December 17, 1999; 274(51): 36274 - 36280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. L. Ferris, C. Hall, N. V. Sipsas, J. T. Safrit, A. Trocha, R. A. Koup, R. P. Johnson, and R. F. Siliciano
Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization
J. Immunol., February 1, 1999; 162(3): 1324 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Tokunaga, C. Brostrom, T. Koide, and P. Arvan
Endoplasmic Reticulum (ER)-associated Degradation of Misfolded N-Linked Glycoproteins Is Suppressed upon Inhibition of ER Mannosidase I
J. Biol. Chem., December 22, 2000; 275(52): 40757 - 40764.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.